|
Re: Possibility?
|
|
Resverlogix Corp.
|
May 08, 2024 04:08PM
|
|
Re: Possibility?
|
|
Resverlogix Corp.
|
May 08, 2024 12:18AM
|
|
Re: a $6 sell order drops ZEN 96% !
|
3
|
Zenith Epigenetics
|
May 02, 2024 04:35PM
|
|
Re: Hepa Links up close to the max 10% in early trading
|
1
|
Resverlogix Corp.
|
Apr 30, 2024 01:44PM
|
|
Re: Wonder if Don will
|
1
|
Resverlogix Corp.
|
Apr 29, 2024 11:42PM
|
|
Re: Wonder if Don will
|
1
|
Resverlogix Corp.
|
Apr 29, 2024 05:05PM
|
|
Re: Wonder if Don will
|
1
|
Resverlogix Corp.
|
Apr 29, 2024 12:22PM
|
|
Re: Report Of Exempt Distribution.
|
2
|
Zenith Epigenetics
|
Apr 18, 2024 12:30AM
|
|
Re: Another victory for our Chief Saboteur
|
3
|
Resverlogix Corp.
|
Mar 15, 2024 11:23AM
|
|
A Bio investor must
|
4
|
Resverlogix Corp.
|
Mar 04, 2024 01:20PM
|
|
A bio investor must
|
1
|
Zenith Epigenetics
|
Mar 04, 2024 01:18PM
|
|
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
|
|
Zenith Epigenetics
|
Mar 01, 2024 11:55AM
|
|
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
|
7
|
Zenith Epigenetics
|
Feb 29, 2024 11:15PM
|
|
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
|
8
|
Zenith Epigenetics
|
Feb 29, 2024 02:48PM
|
|
Re: Lu stepping down
|
1
|
Resverlogix Corp.
|
Feb 23, 2024 02:27PM
|
|
Re: Lu stepping down
|
2
|
Resverlogix Corp.
|
Feb 23, 2024 12:28PM
|
|
Re: Lu stepping down
|
3
|
Resverlogix Corp.
|
Feb 22, 2024 09:45PM
|
|
Re: Lu stepping down
|
4
|
Resverlogix Corp.
|
Feb 22, 2024 04:37PM
|
|
Re: Published 8 days ago; review article out of Qatar Univ.
|
4
|
Resverlogix Corp.
|
Feb 16, 2024 08:07PM
|
|
Re: Worth noting imo. Of concern …?
|
3
|
Resverlogix Corp.
|
Feb 05, 2024 06:59PM
|
